|

The Asia-Pacific Mitral & Tricuspid Valve-in-Valve/Valve-in-Ring Registry (AP ViV Registry)

RECRUITINGSponsored by National Heart Centre Singapore
Actively Recruiting
SponsorNational Heart Centre Singapore
Started2025-03-17
Est. completion2035-12
Eligibility
Age21 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07058935

Summary

A retrospective and prospective, observational, multicenter cohort study of consecutive patients undergoing transcatheter mitral/tricuspid ViV or ViR procedure with balloon expandable valve across participating sites in Asia-Pacific.

Eligibility

Age: 21 Years+Healthy volunteers accepted
Inclusion Criteria:

1. Age ≥ 21
2. Had at least one documented Mitral valve-in-valve/valve-in-ring procedure done during the period of 1 Jan 2023 to current date. (Retrospective) OR Planned to undergo a Mitral valve-in-valve/valve-in-ring procedure. (Prospective) OR Had at least one documented Tricuspid valve-in-valve/valve-in-ring procedure done during the period of 1 Jan 2023 to current date. (Retrospective) OR Planned to undergo a Tricuspid valve-in-valve/valve-in-ring procedure. (Prospective)

Exclusion Criteria:

1. Active endocarditis
2. Any other conditions which investigator deems unsuitable for participation.

Conditions2

Heart DiseaseValve Disease, Heart

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.